Indicator summary: Neutral (2 bullish, 2 bearish, 1 neutral). As of 2026-10-15, the close was $234.12: 0.9% above the 50-day average and 6.2% below the 200-day average, which is falling. RSI (14) is 56, in its neutral range. MACD is bullish after a cross in the last 10 days. The stock sits 27% of the way up its 52-week range of $197.78 to $330.10, on 1.0x its 20-day average volume.
| Indicator | Reading | Read |
|---|---|---|
| 50-day average | $231.99 | Price 0.9% above |
| 200-day average | $249.56 | Price 6.2% below, average falling |
| 50 vs 200-day | 50 below 200 | Death-cross alignment |
| RSI (14) | 56 | Neutral range |
| MACD (12, 26, 9) | -1.05 vs -2.33 | Bullish cross in the last 10 days |
| 52-week range | $197.78 to $330.10 | 27% of the way up the range |
| Volume vs 20-day average | 1.0x | Normal |
Base rates use IBM's own daily history since 1999; they describe the past, not a forecast.
As of 2026-10-15, IBM's 14-day RSI is 56, which is in the neutral range between 30 and 70.
No. IBM closed at $234.12 on 2026-10-15, 6.2% below its 200-day average of $249.56, which is falling. When it closed below its 200-day average (2,383 days), it was higher 63 trading days later 70% of the time, median +5.3%.
Yes. IBM closed at $234.12 on 2026-10-15, 0.9% above its 50-day average of $231.99. When it closed above its 50-day average (3,746 days), it was higher 63 trading days later 54% of the time, median +0.9%.
Yes, a bullish cross within the last 10 trading days. As of 2026-10-15 the MACD line is -1.05 against a signal line of -2.33, so MACD is bullish.
No. At $234.12 it sits 27% of the way up its 52-week range of $197.78 to $330.10, 29.1% below the high.
Neutral: 2 of 5 indicators are bullish and 2 bearish as of 2026-10-15 (the 50 and 200-day averages, their alignment, RSI and MACD). A rating summarises the chart; it is not a recommendation.
ŷRobot chart signal: Bearish, from the chart signal model.
IBM analysis: AI score, fair value and forecast · Is it a bull or a bear market today? · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.